Skip to main content
. 2018 Dec 21;63(1):e00822-18. doi: 10.1128/AAC.00822-18

FIG 3.

FIG 3

Pharmacodynamics of tedizolid against MSSA ATCC 29213 in immunocompetent (IC) and neutropenic (immunosuppressed [IS]) mice. Mice were inoculated with 3.6 × 107 CFU/thigh (IC) or 9.3 × 104 CFU/thigh (IS).